Trial Profile
Phase II study assessing the efficacy and safety of lenvatinib for anaplastic thyroid cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Jun 2016 New trial record